chr17-35148131-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001267052.2(UNC45B):c.1-133G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00463 in 985,236 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 31 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 41 hom. )
Consequence
UNC45B
NM_001267052.2 intron
NM_001267052.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.256
Genes affected
UNC45B (HGNC:14304): (unc-45 myosin chaperone B) This gene encodes a co-chaperone required for folding and accumulation of type II myosins. The protein consists of three tetratricopeptide repeat motifs at the N-terminus that form a complex with heat shock protein 90, a central region of unknown function that is conserved in all Unc-45 proteins, and a C-terminal Unc-45/Cro1/She4 domain. The protein is expressed at high levels in striated muscle, where its muscle myosin chaperone activity is dependent on heat shock protein 90 acting as a co-chaperone. A missense mutation in this gene has been associated with cataract development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-35148131-G-A is Benign according to our data. Variant chr17-35148131-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1214292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0105 (1593/152250) while in subpopulation EAS AF= 0.0387 (200/5170). AF 95% confidence interval is 0.0343. There are 31 homozygotes in gnomad4. There are 808 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1593 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UNC45B | NM_001267052.2 | c.1-133G>A | intron_variant | ENST00000394570.7 | |||
UNC45B | NM_001033576.2 | c.-3-130G>A | intron_variant | ||||
UNC45B | XM_017024234.2 | c.1-133G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UNC45B | ENST00000394570.7 | c.1-133G>A | intron_variant | 1 | NM_001267052.2 | P4 | |||
UNC45B | ENST00000268876.9 | c.-3-130G>A | intron_variant | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1585AN: 152132Hom.: 30 Cov.: 32
GnomAD3 genomes
AF:
AC:
1585
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00356 AC: 2968AN: 832986Hom.: 41 AF XY: 0.00392 AC XY: 1655AN XY: 422094
GnomAD4 exome
AF:
AC:
2968
AN:
832986
Hom.:
AF XY:
AC XY:
1655
AN XY:
422094
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0105 AC: 1593AN: 152250Hom.: 31 Cov.: 32 AF XY: 0.0109 AC XY: 808AN XY: 74442
GnomAD4 genome
AF:
AC:
1593
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
808
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
56
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 24, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at